Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Phio Pharmaceuticals stock
Learn how to easily invest in Phio Pharmaceuticals stock.
Phio Pharmaceuticals Corp is a biotechnology business based in the US. Phio Pharmaceuticals shares (PHIO) are listed on the NASDAQ and all prices are listed in US Dollars. Phio Pharmaceuticals employs 10 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Phio Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PHIO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Phio Pharmaceuticals stock price (NASDAQ: PHIO)Use our graph to track the performance of PHIO stocks over time.
Phio Pharmaceuticals shares at a glance
|Latest market close||$0.88|
|52-week range||$0.82 - $4.36|
|50-day moving average||$1.25|
|200-day moving average||$1.84|
|Wall St. target price||$6.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.13|
Buy Phio Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Phio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phio Pharmaceuticals price performance over time
|1 week (2022-01-14)||-0.77%|
|1 month (2021-12-22)||-26.29%|
|3 months (2021-10-22)||-46.18%|
|6 months (2021-07-22)||-53.59%|
|1 year (2021-01-22)||-69.65%|
|2 years (2020-01-22)||-91.02%|
|3 years (2019-01-22)||159.91%|
|5 years (2017-01-20)||30.24%|
Phio Pharmaceuticals financials
|Gross profit TTM||$-4,431,000|
|Return on assets TTM||-33.9%|
|Return on equity TTM||-60.43%|
|Market capitalisation||$12 million|
TTM: trailing 12 months
Phio Pharmaceuticals share dividends
We're not expecting Phio Pharmaceuticals to pay a dividend over the next 12 months.
Have Phio Pharmaceuticals's shares ever split?
Phio Pharmaceuticals's shares were split on a 1:55 basis on 14 January 2020. So if you had owned 55 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Phio Pharmaceuticals shares – just the quantity. However, indirectly, the new 5400% higher share price could have impacted the market appetite for Phio Pharmaceuticals shares which in turn could have impacted Phio Pharmaceuticals's share price.
Phio Pharmaceuticals share price volatility
Over the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $0.821 up to $4.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 1.8662. This would suggest that Phio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Phio Pharmaceuticals overview
Phio Pharmaceuticals Corp. , a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies.
Phio Pharmaceuticals in the news
18 Stocks Moving in Friday's Pre-Market Session
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questionsWhat percentage of Phio Pharmaceuticals is owned by insiders or institutions?
Currently 0.333% of Phio Pharmaceuticals shares are held by insiders and 9.168% by institutions. How many people work for Phio Pharmaceuticals?
Latest data suggests 10 work at Phio Pharmaceuticals. When does the fiscal year end for Phio Pharmaceuticals?
Phio Pharmaceuticals's fiscal year ends in December. Where is Phio Pharmaceuticals based?
Phio Pharmaceuticals's address is: 257 Simarano Drive, Marlborough, MA, United States, 01752 What is Phio Pharmaceuticals's ISIN number?
Phio Pharmaceuticals's international securities identification number is: US71880W3034 What is Phio Pharmaceuticals's CUSIP number?
Phio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 71880W204
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Ask an Expert